Cite
HARVARD Citation
Hashmi, H. et al. (2019). Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy. British journal of haematology. pp. e35-e38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hashmi, H. et al. (2019). Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy. British journal of haematology. pp. e35-e38. [Online].